Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Canaccord Lowers Regeneron Price Target After Disappointing Phase 3 Trial Outcome Marvell Technology Shares Surge on Accelerating AIDriven Revenue Growth Outlook PlayStation Plus Price Hikes Draw Criticism From Subscribers Amid Growing Gaming Subscription Costs PutinXi Talks Revive Power of Siberia 2 Pipeline Amid Energy Market Disruptions BitMines Potential Inclusion in Russell 1000 Sparks Market Interest EIKN Q1 2026 Earnings EPS Miss of 38 Amid PreRevenue Stage Stock Drops 9 TPL Q1 2026 Earnings EPS Slightly Beats Estimates Amid Stable Land Operations Exact Sciences Q4 2025 Earnings Significant EPS Miss Highlights Ongoing Investment Challenges YTRA Q1 2026 Earnings EPS Misses Estimates Stock Gains on Strategic Optimism Innoviva Inc INVA Q1 2026 Earnings Significant EPS Miss Amidst Revenue Discrepancy Stock Declines Rand Capital RAND Sees a 15 Upswing as Shares Approach Key Resistance Design Therapeutics DSGN Edges Higher as Support Holds Above 1060 Structure Therapeutics GPCR Edges Higher on Modest Gains Testing Key Resistance Levels Zenta Group ZGM Holds Steady at 165 as Traders Weigh Support and Resistance Levels Brainbees Solutions Narrows Q4 Loss to Rs 303 Crore Revenue Grows 12 to Rs 2163 Crore Italys Antitrust Watchdog Investigates EasyJet Over Baggage Pricing Practices Market Movers LIC Campus Activewear Rise Pine Labs RVNL Fall After Earnings Japanese Automakers Face Margin Squeeze Amid Rising Aluminum Costs and Supply Risks LAZ Q1 2026 Earnings Missed EPS Estimates Revenue Not Disclosed Shares Edge Higher ARE Q1 2026 Earnings Earnings Per Share Soars 1459 Above Estimates Stock Slips Modestly ARDT Q1 2026 Earnings EPS Surges Past Estimates with 486 Beat MGA Q1 2026 Earnings Strong EPS Beat of 33 Propels Stock Higher Ouster Inc OUST Q1 2026 Earnings NarrowerThanExpected Loss and Strong Stock Rally RZLT Q1 2026 Earnings Narrower Loss Surpasses Expectations as Clinical Pipeline Advances